Full Length Research Paper
References
|
Araoye MO (2004). Research Methodology with Statistics for Health and Social Sciences, 1st edition, Ilorin, Nathadex publishers; 115-125. |
|
|
Aweke M, Zelalem D, Essey M, and Demeke W (2016). Prevalence and associated factors of TB/HIV co-infection among HIV infected patients in Amhara region, Ethiopia. African Health Sciences 16(2):588-595. |
|
|
Awoyemi OB, Ige M, Onadeko BO (2002). Prevalence of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria. African Journal of Medicine and Medical Sciences 31:329-332. |
|
|
Centers for Disease Control and Prevention (CDC) (2011). Vaccine and Immunizations: TB Vaccine (BCG)" |
|
|
Centers for Disease Control and Prevention (CDC) (2009). Division of Tuberculosis Elimination (DTBE). |
|
|
Chaisson RE, Martinson NA (2008). Tuberculosis in Africa-combating an HIV-driven crisis. The New England Journal of Medicine 358(11):1089-1092. |
|
|
Crofton J (1959). Chemotherapy of pulmonary tuberculosis. British Medical Journal 1:1610-1614 |
|
|
Gibson PG, Abramson M, Wood-Baker R, Volmink J, Hensley M, Ulrich Costabel (2005). Evidence-Based Respiratory Medicine (1st ed.). BMJ Books. 321. |
|
|
Gler MT, Podewils LJ, Munez N, Galipot M, Quelapio MI, and Tupasi DT (2012). Impact of patient and program factors on default during treatment of multidrug resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease 16(7):955-960. |
|
|
Gursimrat KS (2011). Tuberculosis: Current Situation, challenges and overview of its control programs in India. Journal of Global Infectious Diseases 3(2):143-150. |
|
|
Hatfull GF, Jacobs WR (2000). Molecular Genetics of Mycobacteria. Washington, D.C. ASM Press. 7-18. |
|
|
Ifebunandu NA, Ukwaja KN, Obi SN (2012). Treatment outcome of HIV-associated tuberculosis in a resource poor setting. Tropical Doctor 42:74–76. |
|
|
Iliyasu Z, Babashani M (2009). Prevalence and Predictors of TB co-infection Among HIV Seropositive Patients attending Aminu Kano Teaching Hospital, Northern Nigeria. International Journal of Epidemiology 19(2):81-87. |
|
|
Kielstra P (2014). Zoe Tabary, ed. "Ancient enemy, modern imperative – a time for greater action against tuberculosis". Economist Insights. The Economist Group. |
|
|
Kumar V, Abbas AK, Fausto N, Mitchell RN (2007). Robbins Basic Pathology. Saunders Elsevier. 8th ed. P 935. |
|
|
Mandell GL, Bennett JE, Dolin R (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases (7th ed.). Philadelphia, PA: Churchill Livingstone/Elsevier. 250:11 |
|
|
Maryn M (2012). Totally Resistant TB: Earliest Cases in Italy". Wired. Archived from the original on 14 January 2012. |
|
|
Migliori GB, De Iaco G, Besozzi G, Centis R, Cirillo DM (2007). First tuberculosis cases in italy resistant to all tested drugs. Eurosurveillance. 12(5):E070517.1. |
|
|
Morello, Josphine A, Paul A, Granato, Mario E, Wilson, Verna Morton (2006). Laboratory Manual and Workbook in Microbiology: Applications to patients care. 10th ed. Boston. McGrawHill Higher Education New York |
|
|
Nester EW, Anderson DN, Roberts EC, and Nester MT (2007). Microbiology. A Human Perspective. 5th edition, Boston MA, McGraw Hill. pp. 455-457. |
|
|
Nigerian Medical Association (NMA) (2013). 27,000 Nigerians die of tuberculosis yearly. |
|
|
Nwobu GO, Okodua MA, Tatfeng Y, Mirabeau (2004). Comparative study of HIV associated pulmonary tuberculosis in Chest Clinics from two regions of Edo State, Nigeria. Journal of Health and Allied Sciences 3:4. |
|
|
O'Brien R (1994). Drug-resistant tuberculosis: Etiology, management and prevention. Seminars in Respiratory Infections 9(2):104-112. |
|
|
Ojiezeh TI, Ogundipe OO, Adefosoye VA (2015). A retrospective study of the incidence of pulmonary tuberculosis and human immunodeficiency virus co- infection among patients attending national tuberculosis and leprosy control programme, Owo Centre. Pan African Medical Journal 20:1. |
|
|
Onubogu CC, Kunle-Ope CN, Onyejepu N, Nwokoye NN, Raheem TY, Igbasi UT, Tochukwu NE, Omoleye RM, Ejezie CO, Musa AZ, Odunukwe NN, Onwujekwe DI, Idigbe EO (2010). Prevalence of tuberculosis and human immune deficiency Virus (TB/HIV) co-infection amongst patients with broncho pulmonary disorders in Lagos. African Journal of Microbiology Research 4(18):1904-1908. |
|
|
Peter R, Donald B, Chan M, and Paul D (2009). The global burden of tuberculosis-combating drug resistance in difficult times. The New England Journal of Medicine 360:2393-2395. |
|
|
Rajasekaran S, Mahilmaran A, Annadurai S, Kumar S, Raja K (2007). Manifestation of tuberculosis in patients with human immunodeficiency virus: A large Indian study. Annals of Thoracic Medicine 2:58-60. |
|
|
Tsaku IM, Akyala I, Amuta EU (2011). A retrospective study on the mortality rate of human immunodeficiency virus (HIV) and pulmonary tuberculosis (PTB) co-infected individuals in Nasarawa State, Nigeria. Journal of Biology, Agriculture and Healthcare 3(7):218-224. |
|
|
World Health Organization (WHO) (2005). Anti-Tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Report No. 3. Prevalence and Trends. WHO/HTM/TB/2004.343. Geneva, Switzer-land. |
|
|
World Health Organization (WHO) (2008). Implementing the WHO Stop TB Strategy: a Handbook for National TB Control Programmes. Geneva: 179. |
|
|
World Health Organization (WHO) (2009). Epidemiology. Global tuberculosis control: epidemiology, strategy, financing mates of TB burden. 6-33. |
|
|
World Health Organization (WHO) (2010). Tuberculosis. In: Raviglione Mario C., editor. The Essentials. Fourth Edition. Geneva Switzerland: World Health Organization, 2010. |
|
|
World Health Organization (WHO) (2011). WHO report 2011: Global tuberculosis control. Geneva, Switzerland: WHO; 2011. WHO/HTM/TB/2011.16. |
|
|
World Health Organization (WHO) (2012). Global Tuberculosis Report. |
|
|
World Health Organization (WHO) (2015). Global Strategy and Targets for Tuberculosis Prevention, Care and Control after 2015 (Geneva, Switzerland). |
|
|
World Health Organization (WHO) (2016). Totally Drug-Resistant TB: a WHO consultation on the diagnostic definition and treatment options (PDF). who.int. World Health Organization. Archived (PDF). Retrieved 25 March 2016. |
|
|
World Health Organization (WHO) (2017). Retrieved 2017-11-09. Global tuberculosis report". |
|
|
Zumla A, Mario R, Richard H, Fordham C (2013). Tuberculosis. The New England Journal of Medicine 368:745-55. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
